179 related articles for article (PubMed ID: 15924146)
1. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin.
Stech J; Garn H; Wegmann M; Wagner R; Klenk HD
Nat Med; 2005 Jun; 11(6):683-9. PubMed ID: 15924146
[TBL] [Abstract][Full Text] [Related]
2. A new approach to an influenza life vaccine: haemagglutinin cleavage site mutants generated by reverse genetics.
Stech J; Klenk HD
Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):186-91. PubMed ID: 16573209
[TBL] [Abstract][Full Text] [Related]
3. The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.
Gabriel G; Garn H; Wegmann M; Renz H; Herwig A; Klenk HD; Stech J
Vaccine; 2008 Feb; 26(7):956-65. PubMed ID: 18164519
[TBL] [Abstract][Full Text] [Related]
4. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
5. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
[TBL] [Abstract][Full Text] [Related]
6. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
Stech J
Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
[TBL] [Abstract][Full Text] [Related]
7. Influenza B virus with modified hemagglutinin cleavage site as a novel attenuated live vaccine.
Stech J; Garn H; Herwig A; Stech O; Dauber B; Wolff T; Mettenleiter TC; Klenk HD
J Infect Dis; 2011 Nov; 204(10):1483-90. PubMed ID: 21917878
[TBL] [Abstract][Full Text] [Related]
8. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
Zhirnov OP; Klenk HD
Virology; 2009 Nov; 394(1):57-63. PubMed ID: 19747708
[TBL] [Abstract][Full Text] [Related]
9. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
10. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
11. Attenuating mutations of the matrix gene of influenza A/WSN/33 virus.
Liu T; Ye Z
J Virol; 2005 Feb; 79(3):1918-23. PubMed ID: 15650216
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
[TBL] [Abstract][Full Text] [Related]
13. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
Kobasa D; Takada A; Shinya K; Hatta M; Halfmann P; Theriault S; Suzuki H; Nishimura H; Mitamura K; Sugaya N; Usui T; Murata T; Maeda Y; Watanabe S; Suresh M; Suzuki T; Suzuki Y; Feldmann H; Kawaoka Y
Nature; 2004 Oct; 431(7009):703-7. PubMed ID: 15470432
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.
Hatta M; Gao P; Halfmann P; Kawaoka Y
Science; 2001 Sep; 293(5536):1840-2. PubMed ID: 11546875
[TBL] [Abstract][Full Text] [Related]
15. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
Lu JH; Long JX; Jia LJ; Liu YL; Shao WX; Zhang YM; Liu XF
Acta Virol; 2006; 50(4):243-9. PubMed ID: 17177609
[TBL] [Abstract][Full Text] [Related]
16. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
[TBL] [Abstract][Full Text] [Related]
17. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
19. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
20. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]